Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development

Surrozen forms Clinical Advisory Board comprised of leading retinal specialists

Read more at globenewswire.com